Xofigo (radium-223-dichloride) - Important Safety Information from Bayer AG as approved by the HPRA (August 2018)

Notice type: 3rd Party Publications

Date: 08/08/2018

 

Problem Or Issue:
Important Safety Information communication from Bayer AG on Xofigo (radium-223-dichloride): new restrictions on use due to increased risk of fracture and trend for increased mortality.

Important Safety Information - Xofigo (radium-223-dichloride)
 


« Back